Skip to content

KORU Medical Systems KRMD Ratios & Valuation

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
Profitability
Gross margin61.9%-0.3pp62.3%-0.1pp62.3%-0.8pp63.2%-0.3pp63.5%+0.1pp
Operating margin-6%+1.2pp-7.2%+3.0pp-10.3%+2.9pp-13.2%+3.2pp-16.3%+2.8pp
Net margin-5.3%+1.1pp-6.4%+3.1pp-9.5%+2.8pp-12.3%+2.8pp-15.1%+2.9pp
EBITDA margin-4.2%+1.1pp-5.3%+2.9pp-8.1%+2.7pp-10.8%+3.0pp-13.8%+2.7pp
Returns
Return on equity-13.7%+1.9pp-15.6%+6.1pp-21.7%+3.9pp-25.6%+4.2pp-29.9%+2.8pp
Return on assets-8.2%+1.4pp-9.5%+4.1pp-13.6%+3.5pp-17.1%+2.3pp-19.4%+2.4pp
Return on invested capital-22.7%+3.3pp-26%+7.1pp-33.1%+6.8pp-40%+8.5pp-48.5%+4.8pp
Efficiency
Asset turnover1.6×+0.1×1.5×+0.1×1.4×0.0×1.4×+0.1×1.3×+0.1×
Inventory turnover4.2×-0.5×4.8×+1.3×3.5×-0.6×4.2×+0.2×+0.2×
Liquidity
Current ratio2.3×-0.1×2.4×0.0×2.5×-0.4×2.9×+0.5×2.4×-0.2×
Quick ratio1.8×-0.2×+0.1×1.9×-0.3×2.3×+0.2×-0.3×
Cash ratio-0.1×1.1×0.0×1.1×-0.3×1.3×+0.2×1.1×-0.2×
Leverage
Debt-to-equity0.2×0.0×0.2×0.0×0.2×0.0×0.2×0.0×0.2×0.0×
Debt-to-assets0.1×0.0×0.1×0.0×0.1×0.0×0.1×0.0×0.1×0.0×
Interest coverage-8.6×
Per Share
Book value per share$0.37-1.1%$0.37+3.7%$0.36-0.5%$0.36+0.6%$0.36-3.2%
Valuation
Market capitalization$206.24M+24.9%$269.13M+52.0%$177.08M+7.8%$164.26M+40.7%$116.73M-33.9%
Enterprise value$200.96M+25.1%$263.88M+53.5%$171.95M+7.7%$159.67M+43.1%$111.59M-34.6%
Price / sales4.8×+0.3×6.5×+2.0×4.5×+0.1×4.5×+1.1×3.3×-1.9×
Price / book12.2×+2.2×15.8×+5.0×10.8×+0.8×9.9×+2.8×7.1×-3.4×
EV / sales4.6×+0.3×6.4×+2.0×4.4×+0.1×4.3×+1.2×3.2×-1.9×
Earnings yield-1.1%+1.6pp-1%+1.1pp-2.1%+0.7pp-2.7%+1.8pp-4.5%-1.1pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are KORU Medical Systems's profit margins?
KORU Medical Systems (KRMD) runs a 61.9% gross margin and a -6.0% operating margin, with a -5.3% net margin.
Where do KORU Medical Systems's ratios come from?
Every ratio is computed from KORU Medical Systems's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.